Robert N Vincent1, John Moore2, Robert H Beekman3, Lee Benson4, Lisa Bergersen5, Ralf Holzer6, Natalie Jayaram7, Kathy Jenkins5, Richard Ringel8, Jonathan Rome9, Gerard R Martin10. 1. 1Department of Pediatrics,Children's Healthcare of Atlanta,Emory University School of Medicine,Atlanta,United States of America. 2. 3Rady Children's Hospital,University of California San Diego,San Diego,United States of America. 3. 4Cincinnati Children's Hospital Medical Center,University of Cincinnati,Cincinnati,United States of America. 4. 5Toronto Hospital for Sick Children,University of Toronto,Toronto,Canada. 5. 6Boston Children's Hospital,Harvard University,Boston,United States of America. 6. 7Sidra Medical Center,Doha,Qatar. 7. 8Children's Mercy Hospitals and Clinics,Kansas City,United States of America. 8. 10Johns Hopkins Children's Center,Johns Hopkins University,Baltimore,United States of America. 9. 11Children's Hospital of Philadelphia,University of Pennsylvania,Philadelphia,United States of America. 10. 12Children's National Health System,George Washington University,Washington,District of Columbia,United States of America.
Abstract
OBJECTIVES: To report procedural characteristics and adverse events on data collected in the registry. BACKGROUND: The IMPACT--IMproving Paediatric and Adult Congenital Treatment--Registry is a catheterisation registry of paediatric and adult patients with CHD undergoing diagnostic and interventional cardiac catheterisation. We are reporting the procedural characteristics and adverse events of patients undergoing diagnostic and interventional catheterisation procedures from January, 2011 to March, 2013. METHODS: Demographic, clinical, procedural, and institutional data elements were collected at the participating centres and entered via either a web-based platform or software provided by American College of Cardiology-certified vendors, and were collected in a secure, centralised database. Centre participation was voluntary. RESULTS: During the time frame of data collection, 19,797 procedures were entered into the IMPACT Registry. Procedures were classified as diagnostic only (35.4%); one of six specific interventions (23.8%); other or multiple interventions (40.7%); and were further broken down into four age groups. Anaesthesia was used in 84.1% of diagnostic procedures and 87.8% of interventional ones. Adverse events occurred in 10.0% of diagnostic and 11.1% of interventional procedures. CONCLUSIONS: The IMPACT Registry is gathering data to set national benchmarks for diagnostic and certain specific interventional procedures. We are seeing little differences in procedural characteristics or adverse events in diagnostic procedures compared with interventional procedures overall, but there is significant variation in adverse events amongst age categories. Risk stratification and patient acuity scores will be required for further analysis of these differences.
OBJECTIVES: To report procedural characteristics and adverse events on data collected in the registry. BACKGROUND: The IMPACT--IMproving Paediatric and Adult Congenital Treatment--Registry is a catheterisation registry of paediatric and adult patients with CHD undergoing diagnostic and interventional cardiac catheterisation. We are reporting the procedural characteristics and adverse events of patients undergoing diagnostic and interventional catheterisation procedures from January, 2011 to March, 2013. METHODS: Demographic, clinical, procedural, and institutional data elements were collected at the participating centres and entered via either a web-based platform or software provided by American College of Cardiology-certified vendors, and were collected in a secure, centralised database. Centre participation was voluntary. RESULTS: During the time frame of data collection, 19,797 procedures were entered into the IMPACT Registry. Procedures were classified as diagnostic only (35.4%); one of six specific interventions (23.8%); other or multiple interventions (40.7%); and were further broken down into four age groups. Anaesthesia was used in 84.1% of diagnostic procedures and 87.8% of interventional ones. Adverse events occurred in 10.0% of diagnostic and 11.1% of interventional procedures. CONCLUSIONS: The IMPACT Registry is gathering data to set national benchmarks for diagnostic and certain specific interventional procedures. We are seeing little differences in procedural characteristics or adverse events in diagnostic procedures compared with interventional procedures overall, but there is significant variation in adverse events amongst age categories. Risk stratification and patient acuity scores will be required for further analysis of these differences.
Authors: Priscila C Cevallos; Molly J Rose; Laurie B Armsby; Aimee K Armstrong; Howaida El-Said; Susan R Foerster; Andrew C Glatz; Bryan H Goldstein; Michael R Hainstock; Jacqueline Kreutzer; Larry A Latson; Ryan A Leahy; Christopher J Petit; Alejandro Torres; Shabana Shahanavaz; Jeffrey D Zampi; Lisa Bergersen Journal: Pediatr Cardiol Date: 2016-08-08 Impact factor: 1.655
Authors: Michael L O'Byrne; Marisa E Millenson; James M Steven; Matthew J Gillespie; Yoav Dori; Andrew C Glatz; Jonathan J Rome Journal: JACC Cardiovasc Interv Date: 2019-04-10 Impact factor: 11.195
Authors: Michael L O'Byrne; Matthew J Gillespie; Kevin F Kennedy; Yoav Dori; Jonathan J Rome; Andrew C Glatz Journal: Catheter Cardiovasc Interv Date: 2016-05-18 Impact factor: 2.692
Authors: Ada C Stefanescu Schmidt; Aimee Armstrong; Kevin F Kennedy; David Nykanen; Jamil Aboulhosn; Ami B Bhatt Journal: Eur Heart J Date: 2017-07-07 Impact factor: 29.983
Authors: Michael L O'Byrne; Kevin F Kennedy; James M Steven; Kevin D Hill; Reid C Chamberlain; Marisa E Millenson; Christopher L Smith; Yoav Dori; Matthew J Gillespie; Jonathan J Rome; Andrew C Glatz Journal: JACC Cardiovasc Interv Date: 2021-02-22 Impact factor: 11.195
Authors: Christopher M Janson; Maully J Shah; Kevin F Kennedy; V Ramesh Iyer; Tammy L Sweeten; Andrew C Glatz; James M Steven; Michael L O'Byrne Journal: Circ Arrhythm Electrophysiol Date: 2021-06-17